Maravai was launched in 2014 by private equity firm GTCR in partnership with two former Gen-Probe executives.
The joint GenomeWeb/Bank of America survey showed that most respondents had one preferred supplier despite the prevalence of a multitude of online catalogs.
The company will integrate the oligonucleotide manufacturer with two of its existing sections to form a new Nucleic Acid Chemistry business unit.
The arrangement will allow Illumina to market and promote Kailos' research solutions for pharmacogenetic target enrichment.
The certification enables the reagent maker to create optimizing products for use beyond the research market.
Roche said the acquisition will strengthen its next-generation sequencing product offerings.
The partners will combine the sciFlexarrayer with Anteo's reagents to improve the functionality and shelf-life of activated glass and polymer slides and other arrays.
The reagent supplier now has three Japanese distributors following a 2013 deal with GeneDesign as a representative throughout that country.
Sigma-Aldrich will take over distribution of Roche's Biochemical Reagents product portfolio so Roche can focus on other areas of its business.
Qiagen said that Enzymatics' portfolio of reagents are estimated to be used in more than 80 percent of all global NGS sequencing reactions.
The New York Times and ProPublica say that many physicians fail to disclose their financial ties when publishing in medical journals.
The Wall Street Journal reports Human Longevity's valuation has dropped by 80 percent.
Science reports that the US National Cancer Institute is cutting its operating budget by 5 percent.
In PLOS this week: similar variants seen in bullbogs, people with Robinow syndrome; ApoE genotypes in African-American, Puerto Rican populations; and more.